語言

Clarification Statement

2022clarification

基因體研究中心澄清稿:

最近數月以來有網路股市名嘴及股民誤導,稱翁前院長及馬徹團隊所研發之「去醣棘蛋白及mRNA疫苗」與醣基生醫公司開發的COVID-19 疫苗有關。

基因體研究中心發明人於此澄清,此兩項技術目前正由中央研究院智財處與其他公司進行洽談中,尚未技轉;與醣基生醫公司自行研發的疫苗(CHO-V10),完全無關。

發明人:翁啟惠,馬徹,林國儀

2022年4月19日

Seminars & Events

目前暫無活動

LATEST NEWS

  • Novel MMT-based iron/platinum nanoparticles designed to enhance MRI contrast and HCC treatment +

    Read More
  • mRNA vaccine of SARS-CoV-2 spike protein with deletion of multiple glycosites is broadly protective against variants of concern +

    Read More
  • Learning from nature: StnK3 is the epimerase controlling β-methyl amino acid stereochemistry +

    Read More
  • The critical point to treatment from the inside out: hybrid inorganic/organic nanoparticles with exosomes for cancer treatment +

    Read More
  • Clarification Statement +

    Read More
  • 1
  • 2
  • 3
  • 4